Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Chiron deal

CHIR, Ciba-Geigy (Basel) and New York University will collaborate for three years to develop a

Read the full 156 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE